Clinical trial Recruiting at 2 sites Interventional Ages 18 to 75

Epidural spinal cord stimulation to help breathing after cervical spinal cord injury

Official title: An Exploratory Clinical Trial of Cervical Epidural Spinal Cord Stimulation for Respiratory Recovery in Patients With Cervical Spinal Cord Injury

Run by Zhongda Hospital · NCT07722130 · Data updated 2026-11-12

This trial tests whether adding epidural spinal cord stimulation to standard care can improve breathing in adults with cervical spinal cord injury and respiratory failure.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment20 (estimated)
SponsorZhongda Hospital
Academic / other
Locations2 sites (Nanjing, Jiangsu and 1 other locations)
StatusRecruiting
StartedJune 1, 2026
Main results expectedDecember 31, 2028
Study endsMarch 31, 2029
Registry record updatedSeptember 4, 2026
Trial IDNCT07722130 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-75 with C1-C5 SCI for at least 2 weeks and respiratory failure who can be safely implanted with an epidural stimulator.

Probably not a fit

Patients without adequate device tolerance, with active infection at implant site, or whose respiratory failure is primarily due to non-SCI conditions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, single-arm study enrolls 20 adults with C1-C5 spinal cord injury and respiratory failure to receive epidural spinal cord stimulation implanted over the C3-C5 region, with daily tailored stimulation in addition to standard care. Primary outcomes focus on diaphragm electrical activity (Edi) and its changes, while secondary measures include lung volumes, diaphragm function on ultrasound, cough strength, ventilator-free days, ICU stay, and survival. The trial aims to establish preliminary safety and signals of efficacy to support future randomized studies. Conducted at two Chinese centers, it is investigator-initiated and the first systematic ESCES evaluation for SCI-related respiratory failure.

Why it matters

Potential benefit: If successful, ESCES could improve diaphragm activity and help wean patients from mechanical ventilation.

How similar studies have gone: Previous work in this area is limited; this is the first systematic ESCES study in SCI-related respiratory failure, with limited prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age between 18 and 75 years, with BMI \<30 kg/m².
2. Cervical SCI involving levels C1-C5 for at least 2 weeks.
3. Respiratory failure defined by one or more of the following:

   * Peripheral oxygen saturation \<90% on room air;
   * Arterial oxygen tension (PaO₂) \<60 mmHg;
   * Respiratory acidosis (PaCO₂ \>45 mmHg with pH \<7.35);
   * Requirement for mechanical ventilation.
4. Maximum inspiratory pressure (MIP) \>-15 cmH₂O.
5. Judged by the treating physician to be unable to tolerate continuous ventilator weaning for ≥48 hours due to SCI.
6. Written informed consent provided by the participant or legally authorized representative.

Exclusion Criteria:

1. Active infection at the planned electrode implantation site, severe systemic infection, or existing implanted neurostimulation devices.
2. Respiratory failure primarily caused by severe pneumonia, pulmonary contusion, pneumothorax, hemothorax, chronic obstructive pulmonary disease, or requirement for home oxygen therapy within the previous 6 months.
3. New York Heart Association (NYHA) class III or IV heart failure or implanted cardiac pacemaker.
4. Severe hepatic or renal dysfunction (Child-Pugh class C liver disease or estimated glomerular filtration rate ≤30 mL/min/1.73 m²) or dialysis dependence.
5. Generalized seizures, traumatic brain injury, intracranial hypertension, intracranial aneurysm with Glasgow Coma Scale score ≤12, or neuromuscular disorders affecting respiratory function.
6. Expected survival \<72 hours or refusal of life-sustaining treatment.
7. Pregnancy or breastfeeding.
8. Any other condition considered by the investigator to make study participation inappropriate.

Where it's running

  • The First Affiliated Hospital of Nanjing Medical University
    Nanjing, Jiangsu, China
    Recruiting
  • Zhongda Hospital, Southeast University
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.